Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One-year open-label tolvaptan extension study in chronic hyponatraemia
2004-000452-16Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tolvaptan in hyponatraemia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Primary endpoints: Long-term safety of tolvaptan and Clinical laboratory safety parameters. Started Jul 2004; status: completed.
02
Drugs
tolvaptan
03
Conditions
hyponatraemia
Beyond the preview
Go deeper on 2004-000452-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000452-16.